Summary
- Current Price
- As of today, INDV price is $34.94, up +0.32% on
- Current Price All-Time High
- INDV price is currently -18.38% below its historical high of $42.81 set on
- Market Cap
- INDV current market cap is $4B, up +33.41% over the past 365 days
- PE Ratio
- INDV current PE ratio is 12.41
- Revenue
- INDV current annual revenue is $1.24B, up +4.29% year-over-year
- Next Earnings
- The next earnings release for INDV is on
Profile
| Metric | Value |
|---|---|
| Full Name | Indivior Pharmaceuticals, Inc. |
| Ticker | NASDAQ: INDV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | indivior.com |
| Employees | 827 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $34.94 | |
| Price, 1D Change | +0.32% | |
| $4B | ||
| - | ||
| 12.41 | ||
| 0.42 | ||
| $1.24B | ||
| Revenue, 1Y Change | +4.29% | |
| $1.64 | ||
| EPS, 1Y Change | +3,019.01% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.48 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $1.64 | ||
| EPS Estimate | $4.41 | N/A |
| EPS Est. Change | +168.72% | N/A |
| $1.24B | ||
| Revenue Estimate | $1.33B | N/A |
| Revenue Est. Change | +7.50% | N/A |
| Current Price | $34.94 | |
| Price Target | $50.00 | - |
| Price Tgt. Change | +43.10% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.61 | $0.05 | -96.74% | |
| $2.33 | $1.64 | -29.68% | |
| $4.41 | N/A | +168.72% | |
| $4.88 | N/A | +197.65% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.15B | $1.19B | +3.15% | |
| $1.19B | $1.24B | +4.05% | |
| $1.33B | N/A | +7.50% | |
| $1.40B | N/A | +12.96% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $34.94 | |
| $35.62 | ||
| $38.80 | ||
| $34.32 | ||
| $37.60 | ||
| -$1.18 | ||
| 0.42 | ||
| $1.15 | ||
| 32.91 | ||
| 15.41% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.48 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.24B | ||
| $1.64 | ||
| $993.00M | ||
| 80.15% | ||
| $262.00M | ||
| 21.15% | ||
| $210.00M | ||
| 16.95% | ||
| $282.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -3.58 | ||
| 0.71 | ||
| 0.55 | ||
| - | ||
| 5 | ||
| 3.10 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 12.41 | ||
| 3.10 | ||
| -19.83 | ||
| 8.14 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$98.00M | ||
| $195.00M | ||
| $1.20B | ||
| $652.00M | ||
| $1.30B | ||
| $914.00M | ||
| $351.00M | ||
| $39.00M | ||
| $250.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.03B | ||
| $731.00M | ||
| $246.00M | ||
| $634.00M | ||
| $20.00M | ||
| $0.00 | ||
| $29.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$27.00M | ||
| -$66.00M | ||
| -$30.00M | ||
| $67.00M | ||
| -$94.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | → | |
| Barclays | ||
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | ||
| Craig-Hallum | → | |
| Piper Sandler | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
No data
Screeners with INDV
FAQ
- What is the ticker symbol for Indivior Pharmaceuticals, Inc.?
- The ticker symbol for Indivior Pharmaceuticals, Inc. is NASDAQ:INDV
- Does Indivior Pharmaceuticals, Inc. pay dividends?
- No, Indivior Pharmaceuticals, Inc. does not pay dividends
- What sector is Indivior Pharmaceuticals, Inc. in?
- Indivior Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Indivior Pharmaceuticals, Inc. in?
- Indivior Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Indivior Pharmaceuticals, Inc. based in?
- Indivior Pharmaceuticals, Inc. is headquartered in United States
- When did Indivior Pharmaceuticals, Inc. go public?
- Indivior Pharmaceuticals, Inc. initial public offering (IPO) was on December 29, 2014
- Is Indivior Pharmaceuticals, Inc. in the S&P 500?
- No, Indivior Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Indivior Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Indivior Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Indivior Pharmaceuticals, Inc. in the Dow Jones?
- No, Indivior Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Indivior Pharmaceuticals, Inc. last earnings report?
- Indivior Pharmaceuticals, Inc.'s most recent earnings report was on August 3, 2026
- When does Indivior Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Indivior Pharmaceuticals, Inc. is November 5, 2026
Data Sources & References
- INDV Official Website www.indivior.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1625297/000162828026012237/0001628280-26-012237-index.htm
- INDV Profile on Yahoo Finance finance.yahoo.com/quote/INDV
- INDV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/indv